Skip to main content
Article thumbnail
Location of Repository

Emergency Management of Hypertension in Children

By Dinesh Singh, Olugbenga Akingbola, Ihor Yosypiv and Samir El-Dahr


Systemic arterial hypertension in children has traditionally been thought to be secondary in origin. Increased incidence of risk factors like obesity, sedentary life-styles, and faulty dietary habits has led to increased prevalence of the primary arterial hypertension (PAH), particularly in adolescent age children. PAH has become a global epidemic worldwide imposing huge economic constraint on health care. Sudden acute increase in systolic and diastolic blood pressure can lead to hypertensive crisis. While it generally pertains to secondary hypertension, occurrence of hypertensive crisis in PAH is however rare in children. Hypertensive crisis has been further subclassified depending on presence or absence of end-organ damage into hypertensive emergency or urgency. Both hypertensive emergencies and urgencies are known to cause significant morbidity and mortality. Increasing awareness among the physicians, targeted at investigation of the pathophysiology of hypertension and its complications, better screening methods, generation, and implementation of novel treatment modalities will impact overall outcomes. In this paper, we discuss the etiology, pathogenesis, and management of hypertensive crisis in children. An extensive database search using keywords was done to obtain the information

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2004). a l k n e ra n dS .R .D a n i e l s ,“ S u m m a r yo ft h ef o u r t hr e p o r t on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents,”
  2. (2010). A.McCann et al., “Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction,”
  3. (2002). A.Papayianni,E.Alexopoulos,P.Giamalisetal.,“Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events,”
  4. (1997). Activity and expression of
  5. (2005). Advances in the pathogenesis and management of hypertensive crisis,”
  6. (2005). Amphetamine toxicity in the emergency department,”
  7. (2002). Amphetamine toxicity,”
  8. (1995). Angiotensin receptors: physiology and pharmacology,”
  9. (2008). Are demographic characteristics, health care access and utilization, and comorbid conditions associated with hypertension among US adults?”
  10. (1999). B.J.SobelandL.B.George,Hypertension:AClinician’sGuide to Diagnosis and Treatment, Hanley and Belfus,
  11. (1979). Blindness and paraplegia in severe childhood hypertension,”
  12. (2009). Blood pressure load, proteinuria and renal function in pre-hypertensive children,”
  13. (2009). Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management,”
  14. (2011). Childhood posterior reversible encephalopathy syndrome,”
  15. (1989). Cocaine exposure among children seen at a pediatric hospital,”
  16. (1992). Correlates of nonadherence to hypertension treatment in an inner-city minority population,”
  17. (2003). Cortical blindness in a boy with acute glomerulonephritis,”
  18. (2005). Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome—case report and review of the literature,”
  19. (1997). D e s o u z a ,D .R .D e n g e l ,R .F .M a c k o ,K .C o x ,a n dD .R . Seals, “Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension,”
  20. (1972). E.Ciocatto,G.Fagiano,andG.L.Bava,“Clinicalfeaturesand treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugs,”
  21. (2007). Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension,”
  22. (2009). F o s t e r ,H .A l i ,S .M a m b e r ,R .C .P o l o m e n o ,a n dA .S .
  23. (1992). Francis,“Predisposingfactorsforsevere,uncontrolledhypertension in an inner-city minority population,” The New England
  24. (2010). Genetics of hypertension,”
  25. (2005). Global burden of hypertension: analysis of worldwide data,”
  26. H¨ orl, “Hypertension in end-stage renal disease: different measures and their prognostic significance,” Nephrology DialysisTransplantation,vol.25,no.10,pp.3161–3166,2010.
  27. (2009). Hemolytic uremic syndrome,” in Pediatric Nephrology,E .D .A v n e ra n dD .E l l i s ,E d s .
  28. (2011). Hemolytic uremic syndrome: new developments in pathogenesis and treatment,” International J o u r n a lo fN e p h r o l o gy ,
  29. (1963). High blood pressure trends in children and adolescents in national surveys,
  30. (2007). Hyperperfusion syndromes: insight into the pathophysiology and treatment of hypertensive encephalopathy,”
  31. (2011). Hypertension after kidney transplant,”
  32. (2009). Hypertension after renal transplantation,” Pediatric Nephrology,
  33. (1998). Hypertension and the development of heart failure,”
  34. (2008). Hypertension and the eye,”
  35. (2006). Hypertension in children and adolescents,”
  36. (2011). Hypertension in chronic kidney disease,” in Clinical Hypertension and Vacular Diseases: Pediatric Hypertension,
  37. (2011). Hypertension in pheochromocytoma: characteristics and treatment,”
  38. (2006). Hypertensive crisis: hypertensive emergencies and urgencies,”
  39. (1996). Hypertensive encephalopathy in childhood,”
  40. (1995). Hypertensive encephalopathy in children: neuroimaging and treatment,”
  41. (1983). Hypertensive retinopathy in the newborn infant,”
  42. (2004). Hypertensive retinopathy,” The New England
  43. (1992). Hypertensive retinopathy: a cause of decreased visual acuity in children,”
  44. Hypertensive retinopathy. Description, classifi-cation, and prognosis,”
  45. (1996). Hypertensive urgencies and emergencies: prevalence and clinical presentation,”
  46. (2005). IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly,”
  47. (2010). Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies,”
  48. (1981). Infarction of the optic nerve head in children with accelerated hypertension,”
  49. (2011). Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans,”
  50. (2012). Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage,”
  51. (2004). Intima-media thickness and arterial elasticity in hypertensive children: controlled study,” Pediatric Nephrology,v o l .1 9 ,n o .7 ,p p .
  52. (2008). Is hypertension an immunologic disease?”
  53. (2003). Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?”
  54. (2009). K h o u r y ,M .M i t s n e f e s ,S .R .D a n i e l s ,a n dT .R . Kimball, “Age-specific reference intervals for indexed left ventricular mass in children,”
  55. (2007). K.L.M cN iec e,T .S.P o ffenbarger,J.L.Turner,K.D.Franco,J. M.Sorof,andR.J.Portman,“Prevalenceofhypertensionand pre-hypertension among adolescents,”
  56. (2009). Laparoscopic adrenalectomy for adrenal tumors in children: a case series,”
  57. (2006). Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension,”
  58. (2011). M u l l e r ,H .K v a k a n ,a n dF .C .L u f t ,“ I m m u n e - r e l a t e d effects in hypertension and target-organ damage,”
  59. (2006). M.B.Lande,N.L.Carson,J.Roy,andC.C.Meagher,“Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study,”
  60. (1997). M.Thorp,D.Toombs,andB.Harmon,“Monoamineoxidase inhibitor overdose,”
  61. (1976). Malignant hypertension and microangiopathic hemolytic anemia,”
  62. (1992). Management of hypertensive emergencies,”
  63. (2008). Mechanisms of acute cocaine toxicity,”
  64. (2008). Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction,”
  65. (1995). Neonatal hypertension and cardiac failure,”
  66. Neonatal hypertension: diagnosis and management,”PediatricNephrology,vol.14,no.4,pp.332–341,2000.
  67. Neurological complications of arterial hypertension,”
  68. (2011). Nitric oxidesynthases: regulation and function,” European Heart Journal.
  69. (2004). o n e sa n dJ .E .H a l l ,“ S e v e n t hr e p o r to ft h ej o i n t national committee on prevention, detection, evaluation, and treatment of high blood pressure and evidence from new hypertension trials,”
  70. (2002). Obesity hypertension in children: a problem of epidemic proportions,”
  71. (2011). Oxidative stress and endothelial dysfunction in hypertension,”
  72. (2011). Oxidative stress and vascular damage in hypertension: role of angiotensin II,”
  73. (2010). Pathogenesis and clinical physiology of hypertension,”
  74. (2003). Pathogenesis of hypertension,”
  75. (2008). Pharmacological interventions for hypertensive emergencies,”
  76. (2012). Posterior reversible encephalopathy syndrome in children with kidney diseases,”
  77. (2010). Potential role of the (pro)renin receptor in cardiovascular and kidney diseases,”
  78. (2009). Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension,”
  79. (1963). Prevalence of Obesity Among Children and Adolescents: United States, Trends
  80. (2007). Recent advances in the diagnosis and treatment of pheochromocytoma in children,”
  81. (2005). Renal tubular transportand the genetic basis of hypertensive disease,”
  82. (1980). Renin-angiotensinaldosterone and hypertension,”
  83. (2008). Renovascular hypertension in children,”
  84. (2005). Renovascular hypertension,”
  85. (1987). Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma,” The New England
  86. (2004). Risk factors for hypertensive crisis:importance of out-patient blood pressure control,” Family Practice,
  87. (2011). Role of T lymphocytes in angiotensin IImediated microvascular thrombosis,”
  88. (2009). Role of the immunesysteminhypertensivetargetorgandamage,”Trends in
  89. (2004). S o r o f ,D .L a i ,J .T u r n e r ,T .P o ffenbarger, and
  90. (2010). Severe renal failure and microangiopathic hemolysis induced by malignant hypertension—case series and review of literature,”
  91. (2011). The association betweenintima media thickness, central obesity and diastolic blood pressure in obese and owerweight children: a cross-sectional school-based study,” International Journal of Cardiology.
  92. (1991). The cardiovascular effects of cocaine,”
  93. (2011). The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system,oxidative stress and endogenous digitalis in the brain,”
  94. (2004). The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry
  95. (2011). The optometrist’s role in the management of hypertensive crises,”
  96. (1991). The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension,”
  97. (2011). The role of oxidative stress in the pathophysiology of hypertension,”
  98. (2004). The spectrum of cardiovascular disease in children with predialysis chronic kidney disease,”
  99. (2010). Thrombotic microangiopathy: new insights,”
  100. (2008). Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome
  101. (2009). Update on pediatric pheochromocytoma,”
  102. (2010). Value of retinal examination in hypertensive encephalopathy,” J o u r n a lo fH u m a nH y p e r t e n s i o n ,
  103. (1964). Vascular crises associated with monoamine-oxidase inhibitors,”
  104. (2001). Visual outcome of malignant hypertension in young people,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.